This week in Healthcare: Bayer reaches $2B deal to resolve future Roundup lawsuits

Hospital and Healthcare
Mergers & Acquisitions
Boston Scientific to acquire Preventice Solutions for $925 million in cash, up to $300 million in potential milestone payments
This acquisition will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space. Read More>>
The Ensign Group acquires Texas skilled nursing facility  
The acquisition brings Ensign’s growing portfolio to 232 healthcare operations, 24 of which also include assisted living operations, across thirteen states. Ensign owns 94 real estate assets. Read More>>

Executive Movement
Manny Ohonme named chair of Sanford International Board  
Ohonme moves to chair of the Sanford International Board after serving as vice chair for the past two years. Read More>>
Premier Inc. President Michael J. Alkire to succeed Susan DeVore as chief executive officer  
Alkire will lead the evolution of Premier’s Performance Services business, which combines artificial intelligence (AI)-driven technology, data and actionable insights with wraparound implementation services to improve health outcomes and reduce total costs. Read More>>

Humana teams up with startup DispatchHealth to expand in-home care services 
The agreement will provide members living with multiple chronic conditions—such as cellulitis, kidney and urinary tract infections, chronic obstructive pulmonary disease, heart failure and many others—an opportunity to be treated safely at home and thereby avoid hospital visits. Read More>>

Center setup and Expansion
Penn Medicine opens surgical supply facility 
In the nearly 110,000-square-feet facility, staff will sterilize thousands of instruments daily in preparation for surgeries and procedures and then package them. These instruments range from scissors and clamps to advanced robotic instruments. Read More>>

Covid vaccine update
Health leaders say Johnson & Johnson vaccine could be a “game changer” 
Johnson & Johnson’s doses can remain stable for two years at -4-degree temperatures or at least three months when stored at 36-to-46-degree temperatures. Read More>>
Thousands vaccinated at Bank of America Stadium 
Atrium Health’s began to vaccinate just under 20,000 people but due to “increased efficiency” more appointments were opened for eligible patients to be vaccinated. Read More>>
Bayer reaches $2B deal to resolve future Roundup lawsuits 
The $2 billion deal proposes creating a class of future claimants who have been diagnosed with non-Hodgkin’s lymphoma and who were exposed to Roundup before their diagnosis. Read More>>
BioNTech-Pfizer pledges 75 million more vaccine doses to European Union 
Companies will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring. Read More>>
Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine 
Under the terms of the contract manufacturing agreement, Novartis plans to take bulk mRNA active ingredient from BioNTech and fill this into vials under aseptic conditions for shipment back to BioNTech for their distribution to healthcare system customers around the world. Read More>>
France’s Sanofi to help rival Pfizer-BioNTech make vaccines 
Sanofi’s Frankfurt facilities will help with late-stage production of vaccines prepared by Germany-based BioNTech, including bottling and packaging. Read More>>

Product Launch
Hanmi launches world’s 1st 4-ingredient combo drug
The drug, which treats hypertension and hyperlipidemia, combines two hypertension treatments (amlodipine and losartan) and two dyslipidemia treatments (rosuvastatin and ezetimibe) by applying Hanmi’s unique and creative formulation technology based on its patents to improve stability improvement and optimize dissolution rate. Read More>>

Mergers and Acquisitions
Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals 
The transaction transfers ownership of the brand portfolio, comprised of Flux®, Decubal®, Lactocare®, Apobase®, Dailycare® and Fludent® from Teva to Karo. Read More>>
Horizon acquires Viela Bio for $3B in a windfall for AstraZeneca  
Viela has sped through the typical biotech milestones, going from newly formed company to commercial drugmaker to acquisition target in just three years. Read More>>

Executive Movement
Almirall names Nazzi as new CEO after Guenter leaves for Merck  
Gianfranco Nazzi will replace Peter Guenter. Nazzi will inherit a determined push by Almirall into the digital health space which has resulted in a number of alliances including a just-signed deal with Happify to develop an app to help psoriasis maintain their mental health. Read More>>
Financial and Market Activity
Pfizer Biosimilar revenues top $525 million in fourth quarter 2020 
Biosimilar operating income of $525 million for the quarter was up 86% compared with the fourth quarter of 2019. Read More>>
Pfizer forecasts $15B in COVID-19 vaccines sales this year 
In the fourth quarter of 2020, Pfizer saw $11.68 billion in revenue versus an expected $11.43 billion. That’s a 12 percent increase over the same period the year prior. Read More>>
Charles River Laboratories taps Cypre for 3D tumor model research
The nonclinical CRO will work with the San Francisco biotech company’s 3D hydrogel technology to boost work on the tumor microenvironment to help predict how well new drugs might work. Read More>>
Gilead and Gritstone Ink $785 Million+ Deal to Develop HIV Cure 
The partnership will leverage Gritstone’s proprietary prime-boost vaccine platform. This is made up of self-amplifying mRNA (SAM) and adenoviral vectors using antigens developed by Gilead. Read More>>
Thermo Fisher Scientific and JW Therapeutics announce CAR-T partnership in China 
The agreement will support the clinical development and commercial manufacturing of leading CAR-T (Chimeric Antigen Receptor T-Cells) therapies in China, including JW Therapeutics’ lead product relmacabtagene autoleucel (“relma-cel”). Relma-cel is an anti-CD19 CAR-T therapy for third-line treatment for relapsed or refractory (“r/r”) B-cell lymphoma. Read More>>
Partnership between Manchester University NHS Foundation Trust and Siemens Healthineers set to transform care delivery in Greater Manchester 
The Value Partnership includes the planning, installation, and maintenance of 222 pieces of critical medical equipment, with approximately 350 planned installations over the life of the contract. Read More>>
Philips to incorporate advanced technologies into Vitas hospitals and clinics 
The agreement will allow Vithas Group hospitals and medical centers to benefit from the latest innovations in diagnostic imaging technology, healthcare informatics, and equipment for minimally-invasive interventional procedures. Read More>>

Product Launch
Philips introduces ClarifEye Augmented Reality Surgical Navigation to advance minimally-invasive spine procedures  
Unique 3D visualization technology – fully integrated in Philips’ Azurion platform – provides live feedback for accurate spine procedures*. Read More>>
AliveCor updates its ECG software to determine three additional heart conditions 
The company hopes that its more descriptive reports will distinguish the personal ECG offering from others limited to atrial fibrillation detection alone. Read More>>
Fujifilm chooses India for first medical screening service 
The service will check for signs of cancer and lifestyle diseases using the company’s medical equipment and artificial intelligence-based diagnosis technology. Read More>>
Mergers and Acquisitions
NextPharma announces agreement to acquire Lonza’s Ploermel and Edinburgh production sites 
With the acquisition, NextPharma plans to develop and broaden its technology offering into lipid based finished dosage forms (softgels and liquid-filled hard capsules), in addition to offering high potency capabilities and new chemical entity development services to customers. Read More>>
Headlines From The Startup World
Startup Spotlight
Latest Insights & Reports
International SOS Account Intelligence Report International SOS is keen on developing innovative tools and solutions to protect the people from COVID-19 pandemic. 
Click here to read here. 
Par Pharmaceutical Account Intelligence Report Par Pharmaceutical specializes in manufacturing sterile products and developing therapeutically equivalent Abbreviated New Drug Application (ANDA) based products. 
Click here to read more. 
Here’s what’s new on our Sales Intelligence Platform
View Number of ‘Active Workflows’
View the number of active workflows with each service provider in the outsourcing section to assess the relationship strength. 
View All Updates
Copyright © *|CURRENT_YEAR|* Zinnov, All rights reserved.

We are located at: *|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

What you should do now

  1. Request a Demo and see how Draup can maximize the impact of your go-to-market teams with AI-driven sales intelligence.
  2. Read more free material about sales intelligence topics in our blog.
  3. If you know someone who’d enjoy this page, share it with them via email, LinkedIn, Twitter, or Facebook.